Keywords: positive, ph, iib, data, ipsat, p1a, helsinki

Positive Ph IIb data for Ipsat P1A

Article | 05 November 2007

Print This

Helsinki, Finland-based Ipsat Therapies says that the Ipsat P1A Phase IIb study met both primary endpoints. The agent is ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in